✦ LIBER ✦

Immunosuppression in pregnant women infected with human immunodeficiency virus

✍ Scribed by R.J. Biggar; S. Pahwa; H. Minkoff; H. Mendes; A. Willoughby; S. Landesman; J.J. Goedert

Book ID: 118889622
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 136 KB
Volume: 32
Category: Article
ISSN: 0020-7292
DOI: 10.1016/0020-7292(90)90367-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human immunodeficiency virus infection i

Human immunodeficiency virus infection in pregnant women in Nigeria

✍ A.S. Sagay; G.E. Imade; E.E. Nwokedi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Human immunodeficiency virus infection i

Human immunodeficiency virus infection in pregnant women in Nigeria

✍ A.S. Saeav; G.E. Imade; M.E. Aliyu; A.O. Aisien; I.A.O. Ujah; E.E. Nwokedi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Treatment options for human immunodefici

Treatment options for human immunodeficiency virus-infected pregnant women

✍ RS Sperling; P Stratton; A Bardeguez; D Cotton; HE Fox; DJ Gloeb; B Gonik; DV La 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Combination antiretroviral therapy in hu

Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women

✍ Elena Visconti; Lucia Pastore Celentano; Enrica Tamburrini; Paola Villa; Giancar 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 136 KB

Combination antiretroviral therapy in hu

Combination antiretroviral therapy in human immunodeficiency virus–infected pregnant women

✍ Joseph P McGowan; Marilyn Crane; Andrew A Wiznia; Steve Blum 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 186 KB

Risk of genital human papillomavirus inf

Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression

✍ Gloria Y. F. Ho; Robert D. Burk; Irene Fleming; Robert S. Klein 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 569 KB

This study examined the risk factors for genital human papillomavirus (HPV) infection, including HIV-related immunosuppression as well as demographic and behavioral factors. Subjects were 207 women with known HIV serologic status, the majority of whom were intravenous drug users recruited from a met